Cite

    Baasch, A., Hüning, I., Gilissen, C., Klepper, J., Veltman, J. A., Gillessen‐Kaesbach, G., Hoischen, A., & Lohmann, K. (n.d.). exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Epilepsia, 55(4), e25–e29. http://access.bl.uk/ark:/81055/vdc_100024825335.0x000042